And Then There Were Three: Time to Move Onward in COPD Drug Development Beyond LAMA/LABA/ICS at Last?
- Published in:
- Pulmonary Therapy, 2018, v. 4, n. 2, p. 115, doi. 10.1007/s41030-018-0059-5
- By:
- Publication type:
- Article
Works matching IS 23641746 AND DT 2018 AND VI 4 AND IP 2
Results: 7
1
2
COPD and Singing for Lung Health: A Patient and Clinician Perspective.
- Published in:
- Pulmonary Therapy, 2018, v. 4, n. 2, p. 121, doi. 10.1007/s41030-018-0063-9
- By:
- Publication type:
- Article
3
Evaluation of Rapid Onset of Action of ICS/LABA Combination Therapies on Respiratory Function in Asthma Patients: A Single-Center, Open-Label, Randomized, Crossover Trial.
- Published in:
- Pulmonary Therapy, 2018, v. 4, n. 2, p. 159, doi. 10.1007/s41030-018-0062-x
- By:
- Publication type:
- Article
4
Home Management of Childhood Asthma Exacerbations.
- Published in:
- Pulmonary Therapy, 2018, v. 4, n. 2, p. 149, doi. 10.1007/s41030-018-0061-y
- By:
- Publication type:
- Article
5
Aerosol Delivery to a Critically Ill Patient: A Big Issue Easily Solved by Developing Guidelines.
- Published in:
- Pulmonary Therapy, 2018, v. 4, n. 2, p. 125, doi. 10.1007/s41030-018-0060-z
- By:
- Publication type:
- Article
6
Patients with Asthma Prescribed Once-Daily Fluticasone Furoate/Vilanterol or Twice-Daily Fluticasone Propionate/Salmeterol as Maintenance Treatment: Analysis from a Claims Database.
- Published in:
- Pulmonary Therapy, 2018, v. 4, n. 2, p. 135, doi. 10.1007/s41030-018-0084-4
- By:
- Publication type:
- Article
7
Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol in Maintenance-Naïve Patients with Moderate Symptomatic Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis.
- Published in:
- Pulmonary Therapy, 2018, v. 4, n. 2, p. 171, doi. 10.1007/s41030-018-0057-7
- By:
- Publication type:
- Article